ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near St Louis, MO, USA:

Cryoablation vs Lumpectomy in T1 Breast Cancers (COOL-IT)

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a ...

Enrolling
Breast Cancer
Breast Neoplasm
Device: Endocare SlimLine Cryoprobe
Procedure: Lumpectomy
The Washington University
The Washington University

Saint Louis, Missouri, United States

Status recently updated

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Active, not recruiting
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Saint Louis, Missouri, United States and 10 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Drug: Avelumab
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Saint Louis, Missouri, United States and 17 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Saint Louis, Missouri, United States and 62 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Saint Louis, Missouri, United States and 117 other locations

OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...

Enrolling
Breast Cancer
Drug: RGT-419B
Drug: RGT-419B in combination with hormonal therapy

Phase 1

Regor Pharmaceuticals

Saint Louis, Missouri, United States and 4 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Saint Louis, Missouri, United States and 226 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Saint Louis, Missouri, United States and 50 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

Saint Louis, Missouri, United States and 64 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Active, not recruiting
Breast Cancer
Drug: Abemaciclib
Drug: ARV-471

Phase 1, Phase 2

Pfizer
Pfizer

Saint Louis, Missouri, United States and 44 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems